The SPf66 Malaria Vaccine: What is the Evidence for Efficacy?
- 1 December 1998
- journal article
- Published by Elsevier BV in Parasitology Today
- Vol. 14 (6), 218-220
- https://doi.org/10.1016/s0169-4758(98)01242-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- How to read a paper: Papers that summarise other papers (systematic reviews and meta-analyses)BMJ, 1997
- Protein particle vaccines against malariaParasitology Today, 1997
- Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of ColombiaVaccine, 1996
- Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern ThailandThe Lancet, 1996
- Efficacy trial of malaria vaccine SPf66 in Gambian infantsThe Lancet, 1995
- Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern TanzaniaThe Lancet, 1994
- Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of EcuadorVaccine, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985